Development of a Qualitative Scale to Asses the Acceptability of Percutaneous Techniques. A Delphi Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversidad de Zaragoza
About this trial
This study aims to develop a new evaluation tool to assess patient acceptability of percutaneous interventions. A Delphi methodology will be implemented, involving the recruitment of a panel of experts in percutaneous interventions and pain management. The scale will be developed through several iterative phases until a final version is reached, comprising clearly defined domains, subdomains, items, and questions to be answered by patients in order to obtain an overall acceptability score for the percutaneous technique received. The scale is intended to be applicable across a wide range of percutaneous interventions and, consequently, to a broad patient population undergoing different percutaneous treatments depending on their clinical condition.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
have at least five years of experience in percutaneous techniques
have clinical experience working with patients with pain
Disqualifiers
None
Trial population
Experts in percutaneous interventions and pain management
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
Iterative focus group sessions and individual evaluation phases
Other interventionThe expert panel conducted iterative focus group sessions and successive individual evaluation phases until consensus was reached on the development of the acceptability scale.
Dry Needling
Other interventionOne session of dry needling
Percutaneous Electrolysis
Other interventionOne session of percutaneous electrolysis
Percutaneous Neuromodulation
Other interventionOne session of percutaneous neuromodulation
Treatment groups
65 Participants
are divided into 4 treatment groupsGroup A: Experts Panel1 intervention
Group B: Dry Needling Patients1 intervention
Group C: Percutaneous Electrolysis Patients1 intervention
Group D: Percutaneous Neuromodulation Patients1 intervention
Trial outcomes
Primary outcomes
1
Consensus among the experts
Consensus must be achieved among the experts panel to establish final decisions on the acceptability scale development.
Time frame
Consensus will be achieved through 5 evaluation phases: Day 1 after first focus group Day 7 after second focus group Month 1 after first individual evaluation Month 2 after second individual evaluation Month 4 after second individual evaluationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov